• Molecular NameRescinnamine
  • SynonymMethyl Trimethoxycinnamoylreserpate; Recinnamine; Rescinnamin; Reserpinene; Reserpinin; Reserpinine; Trimethoxycinnamoyl Methyl Reserpate
  • Weight634.726
  • Drugbank_IDDB01180
  • ACS_NO24815-24-5
  • Show 3D model
  • LogP (experiment)N/A
  • LogP (predicted, AB/LogP v2.0)4.65
  • pkaN/A
  • LogD (pH=7, predicted)4.52
  • Solubility (experiment)Insoluble
  • LogS (predicted, ACD/Labs)(ph=7)-4.73
  • LogSw (predicted, AB/LogsW2.0)0.0
  • Sw (mg/ml) (predicted, ACD/Labs)0.0
  • No.of HBond Donors1
  • No.of HBond Acceptors11
  • No.of Rotatable Bonds11
  • TPSA117.78
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyAn angiotensin-converting enzyme inhibitor used as an antihypertensive drug.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half lifeN/A
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A